Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.24B
-
Number of holders
-
1560
-
Total 13F shares, excl. options
-
1.02B
-
Shares change
-
+15.6M
-
Total reported value, excl. options
-
$73.1B
-
Value change
-
+$1.05B
-
Put/Call ratio
-
1.61
-
Number of buys
-
598
-
Number of sells
-
-795
-
Price
-
$71.64
Significant Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q4 2017
1,772 filings reported holding GILD - GILEAD SCIENCES, INC. - Common Stock as of Q4 2017.
GILEAD SCIENCES, INC. - Common Stock (GILD) has 1,560 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.02B shares
of 1.24B outstanding shares and own 82.32% of the company stock.
Largest 10 shareholders include BlackRock Inc. (104M shares), Vanguard Group Inc (94.8M shares), STATE STREET CORP (56.5M shares), Capital Research Global Investors (32.3M shares), Bank of New York Mellon Corp (30.5M shares), FMR LLC (24.1M shares), PARNASSUS INVESTMENTS /CA (19.2M shares), Invesco Ltd. (17.5M shares), PRICE T ROWE ASSOCIATES INC /MD/ (17.3M shares), and NORTHERN TRUST CORP (16.7M shares).
This table shows the top 1560 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.